A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

A Yale University study uncovers how gut bacteria imbalances may trigger multiple sclerosis (MS), offering new insights into ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Gut microbiome plays a significant role in the onset of multiple sclerosis (MS) -- an autoimmune disease that impacts the ce ...

A new study has found that the gut microbiome plays a crucial role in the development of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The findings may ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...

Multiple Sclerosis Market Growth is Driven by Advanced Treatment Solutions and Rising Patient PopulationsPune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size & Growth Analysis: ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...